Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study

dc.contributor.author	Rutherford, Ole-Christian Walter
dc.contributor.author	Jonasson, Christian
dc.contributor.author	Ghanima, Waleed Khalid
dc.contributor.author	Halvorsen, Sigrun
dc.date.accessioned	2023-05-08T10:38:34Z
dc.date.available	2023-05-08T10:38:34Z
dc.date.created	2020-01-22T10:54:32Z
dc.date.issued	2020
dc.identifier.issn	2055-6837
dc.identifier.uri	https://hdl.handle.net/11250/3066963
dc.language.iso	eng
dc.title	Comparison of dabigatran, rivaroxaban and apixaban for effectiveness and safety in atrial fibrillation; a nationwide cohort study
dc.type	Peer reviewed
dc.type	Journal article
dc.description.version	publishedVersion
dc.source.journal	European Heart Journal (EHJ) - Cardiovascular Pharmacotherapy
dc.identifier.doi	10.1093/ehjcvp/pvz086
dc.identifier.cristin	1779824
cristin.ispublished	true
cristin.fulltext	original
cristin.qualitycode	1